Clinical Trial Update: Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update for nicotinamide in non-alcoholic fatty liver disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Nicotinamide (nicotinamide)

Snippet

Sponsor: Ain Shams University | Conditions: Non Alcoholic Fatty Liver Disease | Phase 2 | Status: COMPLETED